Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi Consumer Healthcare India Ltd

₹ 4,586 -0.68%
31 Jul 11:29 a.m.
sanofi.in BSE: 544250 NSE: SANOFICONR
About

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]

Key Points

Business Overview:[1][2]
SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness

Website BSE NSE
  • Market Cap ₹ 10,562 Cr.
  • Current Price ₹ 4,586
  • High / Low ₹ 5,512 / 3,950
  • Stock P/E 39.7
  • Book Value ₹ 151
  • Dividend Yield 1.63 %
  • ROCE 89.9 %
  • ROE 71.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 77.6%
  • Company has been maintaining a healthy dividend payout of 49.3%

Cons

  • Stock is trading at 30.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
210 225 222 172 160 171 173 221 234 251 229 236
116 135 140 109 97 109 109 151 149 161 140 146
Operating Profit 95 90 82 64 63 62 64 70 85 90 89 89
OPM % 45% 40% 37% 37% 39% 36% 37% 32% 36% 36% 39% 38%
1 1 3 -24 3 2 5 12 3 5 6 6
Interest 0 0 0 0 3 0 0 0 1 0 0 0
Depreciation 1 1 1 1 2 1 2 3 3 3 3 3
Profit before tax 95 90 84 39 61 63 67 79 84 90 91 92
Tax % 25% 24% 25% 25% 26% 29% 25% 23% 25% 27% 25% 25%
71 68 63 29 45 44 50 61 63 66 68 69
EPS in Rs 12.59 19.54 19.24 21.71 26.36 27.31 28.87 29.44 29.87
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2023 8m Dec 2024 Mar 2025 Dec 2025 TTM
555 724 878 878 950
337 454 569 569 597
Operating Profit 219 271 309 309 353
OPM % 39% 37% 35% 35% 37%
2 -15 25 25 20
Interest 0 4 2 2 2
Depreciation 2 4 12 12 13
Profit before tax 219 247 320 320 357
Tax % 25% 27% 25% 25%
165 181 240 240 266
EPS in Rs 78.59 104.25 104.25 115.49
Dividend Payout % 6% 70% 0% 72%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 31%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 34%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -6%
Return on Equity
10 Years: %
5 Years: %
3 Years: 78%
Last Year: 72%

Balance Sheet

Figures in Rs. Crores

Dec 2023 Dec 2024 Dec 2025 Jun 2026
Equity Capital 2 23 23 23
Reserves 206 250 361 325
0 20 25 21
138 138 138 338
Total Liabilities 345 431 547 706
5 29 36 30
CWIP 3 1 0 0
Investments 0 0 0 0
338 402 511 677
Total Assets 345 431 547 706

Cash Flows

Figures in Rs. Crores

Dec 2023 Dec 2024 Mar 2025 Dec 2025
-0 439 175
0 2 8
2 -116 -134
Net Cash Flow 2 325 48
Free Cash Flow -4 429 167
CFO/OP 2% 208% 85%

Ratios

Figures in Rs. Crores

Dec 2023 Dec 2024 Mar 2025 Dec 2025
Debtor Days 21 7 12
Inventory Days 232 80 98
Days Payable 144 138 126
Cash Conversion Cycle 109 -51 -16
Working Capital Days 134 -33 -4
ROCE % 111% 90%

Insights

In beta
Dec 2023 Dec 2024 Dec 2025
Advertisement & Sales Promotion as % of Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Brand Market Share (IQVIA MAT)
%
Field Force (Medical Representatives)
count
Number of Dealers/Distributors
count
Cities Served
count
HCP Digital Engagement Reach
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
60.40% 60.40% 60.40% 60.40% 71.27% 71.27% 71.27% 71.27% 71.27%
6.03% 5.22% 4.42% 4.52% 3.24% 2.94% 2.83% 2.76% 2.60%
22.60% 23.83% 25.35% 25.48% 16.89% 17.21% 17.33% 17.57% 17.85%
10.98% 10.56% 9.84% 9.59% 8.59% 8.58% 8.57% 8.41% 8.28%
No. of Shareholders 61,09158,58255,73451,85949,63248,80848,07548,41847,511

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls